Literature DB >> 26953841

Preparation of chain-end clickable recombinant protein and its bio-orthogonal modification.

Lin Wang3, Rui Jiang2, Lin Wang3, Yang Liu4, Xue-Long Sun5.   

Abstract

Introducing unique functional group into protein is an attractive approach for site-selective protein modification applications. In this report, we systemically investigated four site-selective strategies to introduce azide functionality into recombinant thrombomodulin (TM456), via direct recombinant expression with unnatural amino acid, chemical, and enzymatic modification for its bio-orthogonal modification application. First, a straightforward recombinant method to express TM456 with azide functionality near C-terminus by replacing methionine with azidohomoanlanine from methionine auxotroph Escherichia coli cell was investigated. Next, a sortase-mediated ligation (SML) method to incorporate azide functionality into the C-terminus of recombinant TM456 was demonstrated. The third is to add azide functionality to the N-terminal amine of recombinant TM456via amidation chemistry, and the fourth is tyrosine selective three-component Mannich reaction to introduce azide functionality to recombinant TM456. Overall, SML of recombinant protein affords the highest overall yield for incorporating azide functionality into the C-terminus recombinant TM456 since the key protein expression step uses natural amino acids. Also, single site modification facilitates the highest TM456 activity.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Azide; Bio-orthogonal modification; Copper-free click chemistry; Sortase A; Thrombomodulin

Mesh:

Substances:

Year:  2016        PMID: 26953841     DOI: 10.1016/j.bioorg.2016.02.010

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  3 in total

1.  Recombinant and chemo-/bio-orthogonal synthesis of liposomal thrombomodulin and its antithrombotic activity.

Authors:  Lin Wang; Rui Jiang; Yang Liu; Maosheng Cheng; Qingyu Wu; Xue-Long Sun
Journal:  J Biosci Bioeng       Date:  2017-07-08       Impact factor: 2.894

2.  End-point modification of recombinant thrombomodulin with enhanced stability and anticoagulant activity.

Authors:  Xia Liu; Mallorie Boron; Yu Zhao; Xue-Long Sun
Journal:  Eur J Pharm Sci       Date:  2019-09-09       Impact factor: 4.384

Review 3.  Broadening the scope of sortagging.

Authors:  Xiaolin Dai; Alexander Böker; Ulrich Glebe
Journal:  RSC Adv       Date:  2019-02-06       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.